Valuation: OrganiGram Holdings Inc

Market Cap 196M 138M 121M 111M 103M 13.17B 199M 1.33B 519M 6.47B 519M 507M 22.42B P/E 2026 *
10.7x
P/E 2027 * 34.9x
Enterprise Value 196M 138M 121M 111M 103M 13.17B 199M 1.33B 519M 6.47B 519M 507M 22.42B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.45x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 14/01/2026
Director of Finance/CFO - 07/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 28/03/2018
Director/Board Member 56 16/12/2018
Director/Board Member 70 16/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 144M
+1.03%+5.35%+55.12%+251.60% 223M
+1.09%+8.82%+19.35%+101.09% 127M
-6.36%-9.20%+36.06%-0.82% 92.84M
-3.57%-0.89%-39.08%-44.68% 59.26M
Average -0.62%+3.40%+17.86%+76.80% 125.56M
Weighted average by Cap. +0.38%+4.34%+31.42%+131.84%

Financials

2026 *2027 *
Net sales 340M 239M 209M 193M 179M 22.78B 344M 2.31B 897M 11.18B 897M 877M 38.77B 441M 310M 272M 250M 232M 29.57B 447M 2.99B 1.17B 14.52B 1.16B 1.14B 50.33B
Net income 18.88M 13.28M 11.63M 10.71M 9.94M 1.27B 19.13M 128M 49.89M 622M 49.86M 48.76M 2.16B 6.53M 4.59M 4.02M 3.7M 3.44M 438M 6.62M 44.35M 17.26M 215M 17.25M 16.87M 746M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-